Fagron NV (ARSUF)
Fagron Market Cap : 1.978B for April 1, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Galapagos NV | 1.922B |
| UCB SA | 57.37B |
| Ion Beam Applications SA | 438.69M |
| Celyad Oncology SA | 15.67M |
| AgomAb Therapeutics NV | 472.79M |
Market Cap Related Metrics
| PE Ratio | 19.22 |
| PS Ratio | 1.837 |
| PEG Ratio | 0.5578 |
| Price to Free Cash Flow | 17.34 |
| Price | 27.00 |
| Earnings Yield | 5.20% |
| PEGY Ratio | 0.5578 |
| Operating PE Ratio | 11.95 |
| Normalized PE Ratio | 19.19 |